Citations

Showing 10 of 108094 citations.

Impact of Exercise Training on Obstructive Sleep Apnea: A Systematic Review and Meta-analysis of Randomized Trials
Olagunju, Abdulbaril , Yamani, Naser, Unzek, Samuel , Lee‐Iannotti, Joyce , Mookadam, Farouk , Mookadam, Martina , Mookadam, Farouk

Mayo Clinic

Journal of Clinical Exercise Physiology | September 30, 2022 | Volume: 11 | Issue: 3 | Pages: 80-90

10.31189/2165-6193-11.3.80 Get It

ABSTRACT Background Randomized controlled trials have highlighted the importance of exercise training on the severity of obstructive sleep apnea (OSA). The primary objective of this meta-analysis was to analyze the data from these studies on the severity of OSA indices as measured by formal polysomnography. The secondary objective was to evaluate the effect of exercise on oxygen desaturation index, body mass index and several metabolic parameters associated with OSA. Methods Two independent reviewers and an experienced librarian searched MEDLINE, EMBASE, COCHRANE, and Scopus and SPORTDiscus databases from January 1, 2000, to October 21, 2021 to identify randomized controlled trials that evaluated the impact of exercise training on OSA severity. Pre-exercise and postexercise training data on the primary and secondary objectives were extracted. Results A total of 11 randomized controlled trials (533 study participants) were identified based on the inclusion criteria. The mean pre-exercise and postexercise reduction in apnea hypopnea index was −6.94 event per hour (95% confidence interval [CI]: −10.74 to −3.13, I2 = 84%). The mean changes in oxygen desaturation index and body mass index were −5.32 events per hour (95% CI: −9.65 to −0.99, I2 = 73%) and −1.21 kg·m−2 (95% CI: −1.80 to −0.62, I2 = 49%) respectively. Conclusion In adult patients with OSA, exercise training was associated with statistically significant reduction in OSA severity.
Outcomes of Malignancy in Adults with Congenital Heart Disease: A Single Center Experience
Venkatesh, Prashanth , Yan, Kimberly , Lluri, Gentian , Bravo‐Jaimes, Katia , Yang, Eric H.

Mayo Clinic

No container title available | September 30, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2109843/v1 Get It

Abstract Background Malignancy is known to be a major cause of death in adult congenital heart disease (ACHD). However, data regarding cardiovascular and cancer-related outcomes in ACHD are lacking. Methods We conducted a retrospective single-center cohort study comprising patients with ACHD and malignancy. The primary outcome was all-cause mortality. Key Secondary outcomes included major adverse cardiovascular and cerebrovascular events (MACCE), cardiotoxicity events and consequent cancer therapy modifications. Results Sixty-eight patients with ACHD and a history of cancer were included in the study. 82% of patients had moderate or great ACHD anatomic complexity. Over a median follow-up of 5 years after cancer diagnosis, 16 (24%) patients died, with 69% of deaths being due to cancer. Univariate predictors of mortality were baseline arrhythmia (OR 3.82, 95% CI 1.15-12.67, p = 0.028), baseline diuretic therapy (OR 3.54, 95% CI 1.04-12.04, p = 0.044) and advanced cancer stage at diagnosis (OR 2.37, 95% CI 1.32-4.25, p = 0.004). MACCE occurred in 40 (59%) patients and was independently predicted by baseline diuretic requirement (OR 9.91, 95% CI 1.12 - 87.85, p = 0.039). A14% incidence of cardiotoxicity was seen; 3 patients needed modification and 1 patient needed temporary interruption of cancer therapy for 2 weeks. Conclusions Considerable mortality occurred in this cohort of patients with ACHD and cancer; most deaths were cancer-related. A high rate of MACCE was observed, yet rates of obligatory modification of cancer therapy due to cardiotoxicity were low.
Single-port robot-assisted perineal radical prostatectomy with the da Vinci XI system: initial experience and learning curve using the cumulative sum method
Yu, Chenhao , Ye, Liyin, Hu, Haiyi, Ni, Kangxin, Xue, Dingwei , Cheng, Sheng , Wang, Hui , Pak, Raymond W., Li, Xu , Zhou, Chenhao , Li, Gonghui

Mayo Clinic

No container title available | September 30, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2073273/v1 Get It

Abstract Background To evaluate the early functional and oncological outcomes of single-port robot-assisted perineal radical prostatectomy (sp-pRARP) using the da Vinci XI system, and analyze its learning curve using the cumulative sum (CUSUM) method. Methods The clinical data of 50 patients who underwent sp-pRARP for localized prostate cancer between May 2020 and May 2022 in our center by a single surgeon were analyzed retrospectively. Demographic information, preoperative and postoperative variables, complications, early functional and oncological outcomes of patients were recorded. The CUSUM method was used to illustrate the learning curve based on operation time. Results All surgeries were completed without conversion. The median (interquartile range, IQR) operation time was 205.0 (82.5) min, whereas the median (IQR) docking time was 30.0 (15.0) min and the console time was 120.0 (80.5) min. The median (IQR) estimated blood loss (EBL) was 50.0 (137.5) mL. Positive surgical margins were detected in five patients (10.0%). The continence rate was 40.9%, 63.6%, 88.4%, 97.7% at the 1, 3, 6 and 12 months after surgery. According to the CUSUM plot, the inflection points of the learning curve were 20 cases, splitting the case series into "early phase" and "late phase." In "late phase" cases, there was less time spent on each step of the operation and less EBL. Conclusions Sp-pRARP using the da Vinci XI system was verified to be a feasible and reliable surgical approach. According to the CUSUM plot, 20 cases was considered the turning point for surgeons to master the novel technique.
Varicose Veins of the Lower Extremity: Doppler US Evaluation Protocols, Patterns, and Pitfalls
Adler, Cameron , Rhee, Annie , Mousa, Abeer, Rhee, Annie , Patel, Maitray D , Adler, Cameron R , Mousa, Abeer, Patel, Maitray D.

Mayo Clinic

RadioGraphics | September 30, 2022 | Volume: 42 | Issue: 7 | Pages: 2184-2200

10.1148/rg.220057 | PMID 36178804 Get It

Dynamic CT Angiography in Vascular Imaging: Principles and Applications
Rajiah, Prabhakar , Weber, Nikkole M. , Loewen, Jennifer M. , Kasten, Holly J., Williamson, Eric , Moore, Alastair , Leng, Shuai , Rajiah, Prabhakar , Weber, Nikkole , Loewen, Jennifer , Kasten, Holly, Leng, Shuai

Mayo Clinic

RadioGraphics | September 30, 2022 | Volume: 42 | Issue: 7 | Pages: E224-E225

10.1148/rg.210177 | PMID 36178805 Get It

An update on the safety of ixazomib for the treatment of multiple myeloma
Goel, Utkarsh , Kumar, Shaji

Mayo Clinic

Expert Opinion on Drug Safety | September 30, 2022 | Volume: 21 | Issue: 9 | Pages: 1143-1160

10.1080/14740338.2022.2130892 | PMID 36178708 Get It

Highlights of Consensus-Based Recommendations for Acute Kidney Injury in Children
Kashani, Kianoush

Mayo Clinic

JAMA Network Open | September 30, 2022 | Volume: 5 | Issue: 9 | Pages: e2229511

10.1001/jamanetworkopen.2022.29511 | PMID 36178696 Get It

O-RADS: Good Enough for Everyday Practice or a Work in Progress?
Baumgarten, Deborah A.

Mayo Clinic

Radiology: Imaging Cancer | September 30, 2022 | Volume: 4 | Issue: 5 | Pages: No page available

10.1148/rycan.220121 | PMID 36178353 Get It

Predictors of electronic health record (EHR) portal registration and frequency of portal use among patients with cancer prior to engagement in the IMPACT Consortium symptom management trials.
Yanez, Betina R. , Flores, Ann Marie , Bian, Jessica , Hassett, Michael J. , Griffin, Joan M. , Wong, Sandra L. , Kroner, Barbara, Preiss, Liliana , Jensen, Roxanne E. , Smith, Ashley Wilder , Popovic, Jennifer R. , Austin, Jessica D. , Mitchell, Sandra A , Osarogiagbon, Raymond U. , Cheville, Andrea

Mayo Clinic

Journal of Clinical Oncology | September 30, 2022 | Volume: 40 | Issue: 28_suppl | Pages: 419-419

10.1200/jco.2022.40.28_suppl.419 Get It

419 Background: The patient portal is part of an electronic health record (EHR) that allows patients to communicate with their healthcare team. The portal also provides a platform for patients to receive and complete symptom surveys that can be directly integrated into the EHR, allowing clinical care teams to monitor symptoms and provide cancer symptom management. The Improving Management of symPtoms during And following Cancer Treatment (IMPACT) consortium, supported by the National Cancer Institute’s Cancer MoonshotSM, aims to improve symptom control for cancer patients through assessment and symptom management interventions deployed via the EHR. This initiative presents an opportunity to examine portal enrollment and variation in use, factors critical to successful implementation, especially among groups that have high cancer symptom burden. To this end, we examine: 1) relationships between portal enrollment prior to the launch of IMPACT interventions and neighborhood broadband access, demographic, and social characteristics; and 2) frequency of pre-intervention portal use for any purpose among enrollees. Methods: Data are derived from two of three IMPACT research centers. Enrollment in and frequency of portal use, mode of accessing the portal (web vs. phone), social, demographic, and cultural factors were extracted from the EHR. Rural Urban Commuting Area (RUCA) codes were used to classify population density and degree of rurality. Broadband access was estimated using 2015-2019 American Community Survey estimates matched to zip codes from enrolled IMPACT patients and classified as a patient’s residence being in a community with high (≥85% of households) or low (< 85% of households) access. Bivariate comparisons and adjusted odds ratios were used to describe all associations. Results: Forty-seven percent of patients (22,596/48,034) were enrolled in the portal prior to the intervention. Patients in zip codes with low broadband access and those who were men, > 65 years old, not White, of Hispanic ethnicity, or disabled or not employed had significantly lower odds of being enrolled in the portal. If enrolled, 21% (n = 4825) used the portal at least once a week. Less variation was found in the average frequency of portal use, but patients younger than 40, and those who were Black, disabled, unemployed, or those who used a mobile device to access the portal had the lowest odds of accessing it at least once a week. Conclusions: Significant disparities in portal enrollment exist across demographic groups and among those with limited broadband access. Among those enrolled, most used the portal less than once a week. Fewer differences in frequency of use were observed by sociodemographic factors. Improving portal enrollment and frequency of use may be critical for symptom management interventions deployed via patient portals.
Assessment of quality improvement priorities to improve care delivery for patients with ovarian cancer.
Smeltzer, Matthew, Black, Destin, Blank, Stephanie V. , Bires, Jennifer , Bupathi, Manojkumar , Drescher, Charles W. , Cliby, William A. , Yemelyanova, Anna , Effange, Doreen, Mangir, Christina , Lucas, Lorna, Senter, Leigha , Thaker, Premal H. , Prescott, Lauren Shore , Boehmer, Leigh

Mayo Clinic

Journal of Clinical Oncology | September 30, 2022 | Volume: 40 | Issue: 28_suppl | Pages: 307-307

10.1200/jco.2022.40.28_suppl.307 Get It

307 Background: In the US, more than 12,000 people die from ovarian cancer annually. Although new treatments have recently become available, ovarian cancer care delivery remains suboptimal. The Association of Community Cancer Centers (ACCC) developed a series of initiatives to improve the quality of care for patients with ovarian cancer. In Phase I, ACCC evaluated the needs of cancer programs, conducted 3 quality improvement (QI) workshops, and developed expert-driven Quality of Care recommendations to aid cancer programs in self-assessment and quality improvement. In Phase II, ACCC invited programs to self-assess their level of care using the Quality of Care recommendations. Methods: In 2022, ACCC surveyed 7 ovarian cancer programs across the US. Developed by a multidisciplinary expert steering committee, the 26-question survey assessed the patient populations served, services provided, diagnostic evaluations performed, access to molecular testing, and a self-assessment of quality care delivery and interest in conducting QI projects related to self-identified needs. The survey was administered in Qualtrics and summarized using descriptive statistics. Results: Surveys were completed by 1 community, 2 comprehensive community, 2 hospital-associated, 1 academic comprehensive, and 1 NCI-designated comprehensive cancer programs. The median annual ovarian cases was 40 [range: 2 to 68]. The 7 programs serve diverse racial/ethnic distribution of patients with ovarian cancer ranging from 55% Black to 60% Asian and 30% Pacific Islander. Five programs have a multidisciplinary team for ovarian cancer. All 5 multidisciplinary teams included gynecologic oncology and pathology; 3 teams also included medical oncology and or radiology colleague(s). Sites assessed their level of care for 7 domains of quality care from 1 (lowest) to 5 (highest). The average score was 4.0 for Care Coordination and Patient Education, Treatment Planning, and Disease Surveillance. Diagnosis and Initial Management scored on average 3.8, Equity in Care 3.25, Prevention and Screening 3.25, and Quality of Life 3.2. Sites ranked areas of interest for future QI projects (1 = area of most interest, 7 = area of least interest). The highest ranked domains were Care Coordination and Patient Education as well as Diagnosis and Initial management (average rankings 2.8). These were followed by Quality of Life (average 3.0), Prevention and Screening (Average 3.8), Treatment Planning (Average 4.4), Equity in Care (Average 5.0), and Disease Surveillance (Average 6.2). Conclusions: This assessment will be used to identify 4 additional sites for Phase II QI workshops. Findings from these projects will be combined, summarized, and disseminated to inform future education opportunities and QI initiatives. This initiative aims to help organize and standardize the care of patients with ovarian cancer and improve patient care coordination.